Biovailability of ivermectin administered orally to dogs

Fink, D.W. and Porras, A.G., 1989. Pharmacokinetics of ivermectin in animals and humans. In: W.C. Campbell (ed),Ivermectin and Abamectin, (Springer-Verlag, New York), 113–130

Fisher, M.H. and Mrozik, H., 1989. Chemistry. I. Structures of the naturally occurring avermectins. In: W.C. Campbell (ed),Ivermectin and Abamectin, (Springer-Verlag, New York), 1–23

Kojima, K., Yamamoto, K., Nakanishi, Y. and Katae, H., 1987. Determination of 22,23-dihydroavermectin B1a in dog plasma using solid-phase extraction and high-performance liquid chromatography.Journal of Chromatography,413, 326–331

Paul, A.J., Todd, K.S., Acre, K.E., Plue, R.E., Wallace, D.H., French, R.A. and Wallig, M.A., 1991. Efficacy of ivermectin chewables and two new ivermectin tablet formulations againstDirofilaria immitis larvae in dogs.American Journal of Veterinary Research,52, 1922–1923

Plue, R.E., Acre, K.E., Coleman, M.W., Currin, S.T., Ellis, A.J. and George, L.W., 1989. Efficacy and field safety of two new ivermectin formulations for the prevention of canine heartworm disease. In: G.F. Otto (ed),Proceedings of the Heartworm Symposium '89, (American Heartworm Society, Washington, DC), 103–106

Schuirmann, D.J., 1987. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.Journal of Pharmacokinetics and Biopharmaceutics,15, 657–680

Stong, J.D., 1987. Determination of ivermectin by fluorescence derivatization.Analytical Chemistry,59, 266–270